On Target Therapeutics LLC
5Patents
5Active
5Granted
51Portfolio score
Filing activity: Mar 13, 2014 → Nov 12, 2021
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10233219B2 | Methods and systems for designing and/or characterizing soluble lipidated ligand agents | Physics | 4 | Active |
| US11197906B2 | Methods of lowering blink reflex for the treatment of dry eye disease | Human Necessities | 2 | Active |
| US11254720B2 | Methods and systems for designing and/or characterizing soluble lipidated ligand agents | Physics | 2 | Active |
| US12053501B2 | Methods for treating symptoms of dry eye disease | Human Necessities | 0 | Active |
| US12060397B2 | Soluble lipidated ligand agents for treating eye inflammation | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.